GIP contributes to obesity development through anabolic effects, leading to fat accumulation and WAT inflammation characterized by elevations in pro-inflammatory chemokines and cytokines such as CCL2 and IL-6 (ref. 38). This evidence concerns the gene CCL2 and obesity disorder.